Keywords: DCF; dichlorofluorescein; DFO; deferoxamine; DHR-123; dihydrorhodamine 123; FAC; ferric ammonium citrate; iNs; induced neurons; IRP1; iron regulatory protein 1; LIP; labile iron pool; NBIA; neurodegeneration with brain iron accumulation; PKAN; pantothenat